FDA: PCNS Drugs Advisory Committee Results for Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times:
F.D.A. Sees Promise in Alzheimer’s Imaging Drug
By GINA KOLATA
The New York Times
Published: January 20, 2011
"A committee voted that the agency should approve the first test that can show the characteristic plaques of Alzheimer’s disease in the brain of a living person."
Read the full article
F.D.A. Sees Promise in Alzheimer’s Imaging Drug
By GINA KOLATA
The New York Times
Published: January 20, 2011
"A committee voted that the agency should approve the first test that can show the characteristic plaques of Alzheimer’s disease in the brain of a living person."
Read the full article
Labels: Alzheimer, amyloid, FDA, neurodegenerative, neuroimaging
posted by Anthony Risser at 8:59 PM
0 Comments:
Post a Comment
<< Home